In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease

被引：2
|
作者：
Awar, Melina [1 ]
Mylonakis, Eleftherios [1 ]
机构：
[1] Houston Methodist Hosp, Houston, TX 77030 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 06期
关键词：
D O I：
10.7326/J23-0039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Source Citation Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161 Clinical Impact Ratings GIM/FP/GP: GIM/FP/GP: Geriatrics: Infectious Disease: Pulmonology: Public Health:
引用
收藏
页码：JC63 / JC63
页数：1
相关论文
共 50 条
  • [41] Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
    Domnich, Alexander
    Orsi, Andrea
    Lai, Piero Luigi
    Massaro, Elvira
    Trombetta, Carlo-Simone
    Pastorino, Julieta
    Roihl, Charlott
    Pianta, Marianna
    Icardi, Giancarlo
    Panatto, Donatella
    MEDICINA-LITHUANIA, 2025, 61 (01):
  • [42] Adults face increased asthma risk after infant RSV bronchiolitis and reduced respiratory health-related quality of life after RSV pneumonia
    Backman, Katri
    Piippo-Savolainen, Eija
    Ollikainen, Hertta
    Koskela, Heikki
    Korppi, Matti
    ACTA PAEDIATRICA, 2014, 103 (08) : 850 - 855
  • [43] BUDGET IMPACT ANALYSIS OF RSVPREF VACCINE FOR PREVENTION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) DISEASE AMONG OLDER ADULTS IN ARGENTINA
    Ares, Rey L.
    Averin, A.
    Zuccarino, N. S.
    Atwood, M.
    Vega, C.
    Sato, R.
    VALUE IN HEALTH, 2024, 27 (12) : S108 - S108
  • [44] Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF-Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study
    Comeaux, Christy A.
    Bart, Stephan
    Bastian, Arangassery Rosemary
    Klyashtornyy, Vladislav
    De Paepe, Els
    Omoruyi, Edmund
    van der Fits, Leslie
    van Heesbeen, Roy
    Heijnen, Esther
    Callendret, Benoit
    Sadoff, Jerald
    JOURNAL OF INFECTIOUS DISEASES, 2023, 229 (01): : 19 - 29
  • [45] Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF-Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study
    Comeaux, Christy A.
    Bart, Stephan
    Bastian, Arangassery Rosemary
    Klyashtornyy, Vladislav
    De Paepe, Els
    Omoruyi, Edmund
    van der Fits, Leslie
    van Heesbeen, Roy
    Heijnen, Esther
    Callendret, Benoit
    Sadoff, Jerald
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (01): : 19 - 29
  • [46] Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
    Mark H. Rozenbaum
    Jen Judy
    Diana Tran
    Kari Yacisin
    Samantha K. Kurosky
    Elizabeth Begier
    Infectious Diseases and Therapy, 2023, 12 : 677 - 685
  • [47] Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
    Rozenbaum, Mark H.
    Judy, Jen
    Tran, Diana
    Yacisin, Kari
    Kurosky, Samantha K.
    Begier, Elizabeth
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (02) : 677 - 685
  • [48] Impact of respiratory syncytial virus (RSV) disease on the quality of life (QoL) of older adults in Europe
    Last, Theo
    Prato, Rosa
    Mital, Marek
    Perez, Silvia Narejos
    Boehme, Georg-Eike
    Gutierrez, Paul Torres
    Bundy, Charles
    Eyre, Susannah
    Joosten, Philip
    Gawade, Shubhangi
    Matthews, Sean
    Cabrera, Eliazar Sabater
    Curran, Desmond
    Molnar, Daniel
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [49] Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease
    Lee, Yu-Na
    Hwang, Hye Suk
    Kim, Min-Chul
    Lee, Young-Tae
    Lee, Jong Seok
    Moore, Martin L.
    Kang, Sang-Moo
    ANTIVIRAL RESEARCH, 2015, 115 : 1 - 8
  • [50] A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study
    Jordan, Elke
    Jenkins, Victoria
    Silbernagl, Gunter
    Chavez, Maria Paulina Velasco
    Schmidt, Darja
    Schnorfeil, Frauke
    Schultz, Stephanie
    Chen, Liddy
    Salgado, Fernanda
    Jacquet, Jeanne-Marie
    Welte, Tobias
    De Moerlooze, Laurence
    VACCINE, 2024, 42 (26)
12345